InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Nolan Mangini Siobhan. Director active across 2 companies, notably NGM Biopharmaceuticals INC. Cumulatively, 5 reports have been published. History available since 2 March 2023. The latest transaction was filed on 2 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Nolan Mangini Siobhan is a declarant linked to Alight, Inc. / Delaware, where he is Director, and to NGM Biopharmaceuticals INC, where he is President and CFO. He has 5 filings in total, and the 5 sampled filings run from 2023-03-06 to 2026-07-07, with buy and sell amounts of EUR 0 in this sample, and the transactions are of Attribution nature.